Lanham O'Dell & Company, Inc. Amgen Inc Transaction History
Lanham O'Dell & Company, Inc.
- $165 Million
- Q1 2025
A detailed history of Lanham O'Dell & Company, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Lanham O'Dell & Company, Inc. holds 741 shares of AMGN stock, worth $201,855. This represents 0.14% of its overall portfolio holdings.
Number of Shares
741Holding current value
$201,855% of portfolio
0.14%Shares
2 transactions
Others Institutions Holding AMGN
# of Institutions
3,305Shares Held
429MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$14.4 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$7.95 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.55 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.42 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $146B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...